Top compounds associated with response to DEFB115


Feature Type Standardized
Nominal ANOVA
mRNA JNK-9L GDSC1000 pan-cancer AAC 0.0068 0.9
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0068 0.9
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC -0.0065 0.9
mRNA XMD8-92 GDSC1000 pan-cancer AAC 0.0088 0.9
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.0061 0.9
mRNA CCT018159 GDSC1000 pan-cancer AAC -0.0062 0.9
mRNA XL765 CTRPv2 pan-cancer AAC 0.0064 0.9
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.0091 0.9
mRNA BYL-719 CTRPv2 pan-cancer AAC 0.0073 0.9
mRNA UNC0321 CTRPv2 pan-cancer AAC 0.0061 0.9
Download CSV